ARCELLX, INC.(ACLX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACLX ARCELLX, INC.

交易中 04-09 15:13:47 EDT

114.80

+0.01

+0.00%

最高114.84	最低114.77	成交量26.43万
今开114.78	昨收114.79	日振幅0.06%
总市值67.13亿	流通市值45.58亿	总股本5,848万
成交额3,035万	换手率0.67%	流通股本3,970万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACLX","market":"US","secType":"STK","nameCN":"ARCELLX, INC.","latestPrice":114.795,"timestamp":1775762024295,"preClose":114.79,"halted":0,"volume":264343,"delay":0,"changeRate":0.000043557801202155696,"floatShares":39702900,"shares":58479800,"eps":-4.069999,"marketStatus":"交易中","change":0.005,"latestTime":"04-09 15:13:47 EDT","open":114.78,"high":114.835,"low":114.77,"amount":30346240.68439,"amplitude":0.000566,"askPrice":114.8,"askSize":1813,"bidPrice":114.79,"bidSize":1186,"shortable":3,"etf":0,"ttmEps":-4.069999,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1775764800000},"marketStatusCode":2,"adr":0,"listingDate":1643950800000,"exchange":"NASDAQ","adjPreClose":114.79,"preHourTrading":{"tag":"盘前","latestPrice":114.78,"preClose":114.79,"latestTime":"09:29 EDT","volume":513,"amount":58894.13907,"timestamp":1775741399907,"change":-0.01,"changeRate":-0.000087,"amplitude":0.000348},"postHourTrading":{"tag":"盘后","latestPrice":114.79,"preClose":114.79,"latestTime":"19:59 EDT","volume":2552,"amount":292944.12,"timestamp":1775692773090,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.342001,"impliedVol":0.0869,"impliedVolPercentile":0.028},"requestUrl":"/m/hq/s/ACLX/tweets","defaultTab":"tweets","newsList":[{"id":"1130614255","title":"吉利德科学再度出手收购癌症药物合作伙伴——市场快讯","url":"https://stock-news.laohu8.com/highlight/detail?id=1130614255","media":"投资观察","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130614255?lang=zh_cn&edition=full","pubTime":"2026-04-07 22:26","pubTimestamp":1775572014,"startTime":"0","endTime":"0","summary":"吉利德科学公司再度出手收购其癌症药物合作伙伴，该公司已达成协议，将以最高50亿美元的价格收购Tubulis公司。今年二月，吉利德宣布将收购ARCELLX, INC.的全部剩余股份，该公司是吉利德在开发针对多发性骨髓瘤这一血癌的潜在CAR-T细胞疗法方面的合作伙伴，该交易对这家生物技术公司的估值在交易完成时约为78亿美元。\nRBC资本市场的分析师指出，此次收购Tubulis是一项战略上合理的补充性收购，既能满足吉利德肿瘤学产品管线增长的需求，又能确保获得差异化的下一代抗体偶联药物平台能力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU1057294990.SGD","LU1037948541.HKD","SG9999015986.USD","LU0122379950.USD","LU0320765992.SGD","SG9999015945.SGD","LU0861579265.USD","LU1430594728.SGD","LU1066051498.USD","IE00B19Z3581.USD","LU1839511570.USD","BK4532","LU0289739699.SGD","IE00BZ1G4Q59.USD","BK4585","LU2112291526.USD","LU1571399168.USD","IE0002270589.USD","LU0234570918.USD","LU1023059063.AUD","IE00BSNM7G36.USD","IE00B3T34201.USD","BK4578","LU1934455863.HKD","BK4588","LU1674673428.USD","LU0882574055.USD","IE00B7SZLL34.SGD","BK4568","LU0109394709.USD","LU0965509101.SGD","LU1934455277.USD","BK4550","LU2468319806.SGD","BK4583","LU1585245621.USD","LU2324357040.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU0965508806.USD","SG9999015952.SGD","SG9999015978.USD","LU1037948897.HKD","LU1778281490.HKD","GILD","LU0114720955.EUR","BK4566","LU1066053197.SGD","LU1934455194.USD","BK4139","LU0965509010.AUD","LU1674673691.USD","ACLX","LU0889565916.HKD","LU2087621335.USD","LU0058720904.USD","LU0965509283.SGD","LU0823416689.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116232732","title":"富国银行下调ARCELLX评级至平配 目标价上调至115美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116232732","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116232732?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:40","pubTimestamp":1771929614,"startTime":"0","endTime":"0","summary":"富国银行最新调整了对细胞疗法公司ARCELLX, INC.的投资评级，将其从\"增持\"下调至\"平配\"。不过，该机构同时将目标股价从100美元提升至115美元，显示出对该公司长期价值的认可。\n此次评级调整反映了分析师在短期风险与长期潜力之间的平衡考量。目标价的上调可能基于ARCELLX在CAR-T细胞治疗领域的技术进展或临床试验数据的积极信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118834824","title":"盘前异动  | Arcellx涨超75%，吉利德科学拟以每股115美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1118834824","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118834824?lang=zh_cn&edition=full","pubTime":"2026-02-23 19:05","pubTimestamp":1771844747,"startTime":"0","endTime":"0","summary":"2月23日，Arcellx盘前涨超75%，吉利德科学将以每股115美元的价格收购Arcellx。","market":"us","thumbnail":"https://static.tigerbbs.com/017a2d51f9605f643f552ed0e3997176","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/017a2d51f9605f643f552ed0e3997176"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1ad4b20488406cf4948c2f1a2f067a59","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU2087621335.USD","LU0965508806.USD","LU2468319806.SGD","LU2089984988.USD","SG9999015952.SGD","LU1585245621.USD","LU0861579265.USD","IE00BSNM7G36.USD","LU1061106388.HKD","SG9999015986.USD","LU0234570918.USD","BK4578","LU0882574055.USD","LU0122379950.USD","LU0320765992.SGD","LU0965509010.AUD","LU0289739699.SGD","LU1023059063.AUD","SG9999015945.SGD","BK4585","LU0889565916.HKD","LU0109394709.USD","LU0058720904.USD","LU1674673691.USD","IE00B19Z3581.USD","LU1057294990.SGD","BK4550","LU1430594728.SGD","BK4568","BK4566","SG9999015978.USD","BK4532","LU1066053197.SGD","LU1778281490.HKD","LU0823416689.USD","LU1839511570.USD","ACLX","LU2112291526.USD","LU0965509101.SGD","BK4588","LU1066051498.USD","IE00B7SZLL34.SGD","BK4139","LU1037948897.HKD","IE00B3T34201.USD","IE0002270589.USD","LU0114720955.EUR","GILD","LU1571399168.USD","LU2324357040.USD","LU1674673428.USD","IE00B19Z3B42.SGD","BK4583","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593462595","title":"创新药板块的强心剂! 富国银行押注Arcellx(ACLX.US)重塑骨髓瘤治疗格局 预言股价将涨超50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593462595","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593462595?lang=zh_cn&edition=full","pubTime":"2025-12-23 14:58","pubTimestamp":1766473090,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华尔街金融巨头富国银行对于美国生物科技新生代势力Arcellx启动评级与目标价覆盖并给予“增持”评级，称其用于多发性骨髓瘤的试验性CAR-T疗法“anito-cel”，是这种血液癌症管理系统中的“未来支柱”，未来将彻底重塑骨髓瘤治疗格局。今年以来Arcellx股价表现不佳，年内迄今跌超15%，大幅跑输标普500指数。在富国银行等知名卖方机构的分析师们看来，anito-cel有望彻底颠覆现有的多发性骨髓瘤治疗市场格局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0477156953.USD","LU0175139822.USD","LU2236285917.USD","LU1814569148.SGD","LU0868494617.USD","LU1506573853.SGD","LU0310800379.SGD","LU1668664300.SGD","06978","LU0048573561.USD","LU1363072403.SGD","LU0154236417.USD","LU0128525689.USD","IE000M9KFDE8.USD","LU0251142724.SGD","LU1035773651.USD","ACLX","BK4139","BK4207","LU0942090050.USD","LU0130102774.USD","LU0314106906.USD","LU2461242641.AUD","LU0417517546.SGD","LU0128525929.USD","LU2361044949.HKD","LU0149725797.USD","LU0971096721.USD","LU0289960550.SGD","BK1574","LU0648001328.SGD","LU0640476718.USD","BK4504","LU2361045086.USD","LU0787776722.HKD","LU1069347547.HKD","LU0130517989.USD","LU1267930490.SGD","BK4559","IE0002270589.USD","IE00B7SZLL34.SGD","159992","LU0683600562.USD","LU1267930227.SGD","LU0211328371.USD","LU0868494708.USD","LU1074936037.SGD","BK1161","LU1791807156.HKD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187648483","title":"ARCELLX, INC. 股份上涨10%，因公司公布其多发性骨髓瘤癌症疗法中期试验的积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1187648483","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187648483?lang=zh_cn&edition=full","pubTime":"2025-12-08 22:34","pubTimestamp":1765204460,"startTime":"0","endTime":"0","summary":"ARCELLX, INC. 股份上涨10%，因公司公布其多发性骨髓瘤癌症疗法中期试验的积极数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173272780","title":"ARCELLX, INC. 股价盘前飙升10.6%，因公司公布复发性和/或难治性多发性骨髓瘤患者研究的积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1173272780","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173272780?lang=zh_cn&edition=full","pubTime":"2025-12-08 18:53","pubTimestamp":1765191194,"startTime":"0","endTime":"0","summary":"ARCELLX, INC. 股价盘前飙升10.6%，因公司公布复发性和/或难治性多发性骨髓瘤患者研究的积极数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154754319","title":"ARCELLX发布其Immagine-1研究在复发性和/或难治性多发性骨髓瘤患者中获得的新积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1154754319","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154754319?lang=zh_cn&edition=full","pubTime":"2025-12-07 03:00","pubTimestamp":1765047610,"startTime":"0","endTime":"0","summary":"ARCELLX发布其Immagine-1研究在复发性和/或难治性多发性骨髓瘤患者中获得的新积极数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517198430","title":"Arcellx, Inc.2024财年实现净利润-1.07亿美元，同比减少51.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517198430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517198430?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363247,"startTime":"0","endTime":"0","summary":"3月8日，Arcellx, Inc.公布财报，公告显示公司2024财年净利润为-1.07亿美元，同比减少51.37%；其中营业收入为1.08亿美元，同比减少1.82%，每股基本收益为-2.00美元。从资产负债表来看，Arcellx, Inc.总负债2.57亿美元，其中短期债务7.54百万美元，资产负债比为2.77，流动比率为4.80。机构评级：截至2025年3月8日，当前有16家机构对Arcellx, Inc.目标价做出预测，其中目标均价为116.12美元，其中最低目标价为104.00美元，最高目标价为134.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000159a2647f15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000159a2647f15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517392607","title":"Arcellx, Inc.盘中异动 临近收盘急速上涨5.01%报68.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517392607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517392607?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:34","pubTimestamp":1741206853,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时34分，Arcellx, Inc.股票出现波动，股价急速拉升5.01%。截至发稿，该股报68.92美元/股，成交量32.6516万股，换手率0.59%，振幅4.96%。Arcellx, Inc.股票所在的生物技术行业中，整体涨幅为1.94%。Arcellx, Inc.公司简介：Arcellx Inc 是一家临床阶段的生物技术公司，通过开发针对癌症和其他不治之症患者的免疫疗法，重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306043413989d93c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306043413989d93c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514354397","title":"Arcellx(ACLX.US)：2024年Q4财报实现营收1526.6万美元，前值为6314.8万美元，预期值为2547万美元；每股收益为-0.87美元，前值为0.42美元，预期值为-0.48美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354397","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514354397?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:08","pubTimestamp":1740697716,"startTime":"0","endTime":"0","summary":"Arcellx(ACLX.US)：2024年Q4财报实现营收1526.6万美元，前值为6314.8万美元，预期值为2547万美元；每股收益为-0.87美元，前值为0.42美元，预期值为-0.48美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28070848442544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ACLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177002654","title":"Arcellx 2024财年GAAP每股收益$(2.00)不及预期$(1.66)，销售额$107.936百万低于预期$121.765百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1177002654","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177002654?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:11","pubTimestamp":1740690666,"startTime":"0","endTime":"0","summary":"Arcellx 2024财年GAAP每股收益$(2.00)，不及预期$(1.66)；销售额$107.936百万，低于预期$121.765百万。以上内容来自Benzinga Earnings专栏，原文如下：Arcellx FY 2024 GAAP EPS $(2.00) Misses $(1.66) Estimate, Sales $107.936M Miss $121.765M Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Arcellx 2024财年GAAP每股收益$(2.00)不及预期$(1.66)，销售额$107.936百万低于预期$121.765百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510133739","title":"Arcellx, Inc.盘中异动 临近午盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510133739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510133739?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:52","pubTimestamp":1739292778,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时52分，Arcellx, Inc.股票出现异动，股价急速下挫5.06%。Arcellx, Inc.股票所在的生物技术行业中，整体跌幅为1.46%。其相关个股中，Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Oramed Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2989.87%、1328.15%、436.81%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、59.46%、58.60%。Arcellx, Inc.公司简介：Arcellx Inc 是一家临床阶段的生物技术公司，通过开发针对癌症和其他不治之症患者的免疫疗法，重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212005259961f603e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212005259961f603e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","BK4539","ACLX","BK4139","OMGA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508141255","title":"Arcellx, Inc.盘中异动 急速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508141255?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:46","pubTimestamp":1738593999,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时46分，Arcellx, Inc.股票出现异动，股价快速下挫5.03%。Arcellx, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为414.08%、351.36%、209.86%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Invivyd, Inc.，振幅分别为82.67%、50.76%、35.62%。Arcellx, Inc.公司简介：Arcellx Inc 是一家临床阶段的生物技术公司，通过开发针对癌症和其他不治之症患者的免疫疗法，重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224639987971cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224639987971cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507672412","title":"Arcellx, Inc.盘中异动 大幅上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507672412","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507672412?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:32","pubTimestamp":1738265569,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时32分，Arcellx, Inc.股票出现异动，股价大幅拉升5.09%。Arcellx, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1793.50%、316.48%、249.15%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited，振幅分别为65.98%、64.10%、61.86%。Arcellx, Inc.公司简介：Arcellx Inc 是一家临床阶段的生物技术公司，通过开发针对癌症和其他不治之症患者的免疫疗法，重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310332499876d223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310332499876d223&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503582053","title":"Arcellx, Inc.盘中异动 大幅下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503582053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503582053?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:16","pubTimestamp":1736784992,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时16分，Arcellx, Inc.股票出现异动，股价快速下挫5.02%。Arcellx, Inc.股票所在的生物技术行业中，整体跌幅为0.96%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为11486.69%、6274.05%、425.42%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、216.61%、150.31%。Arcellx, Inc.公司简介：Arcellx Inc 是一家临床阶段的生物技术公司，通过开发针对癌症和其他不治之症患者的免疫疗法，重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114001633a22058e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114001633a22058e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KAPA","ACLX","KAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502862016","title":"Arcellx, Inc.盘中异动 快速下跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502862016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502862016?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:40","pubTimestamp":1736520044,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时40分，Arcellx, Inc.股票出现波动，股价快速下跌5.38%。截至发稿，该股报68.37美元/股，成交量4.5242万股，换手率0.08%，振幅2.86%。Arcellx, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Arcellx, Inc.公司简介：Arcellx Inc 是一家临床阶段的生物技术公司，通过开发针对癌症和其他不治之症患者的免疫疗法，重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110224044a21d1008&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110224044a21d1008&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501843775","title":"Arcellx, Inc.盘中异动 早盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501843775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501843775?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:39","pubTimestamp":1736347168,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时39分，Arcellx, Inc.股票出现异动，股价快速跳水5.07%。截至发稿，该股报73.14美元/股，成交量2.7843万股，换手率0.05%，振幅4.06%。Arcellx, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Arcellx, Inc.公司简介：Arcellx Inc 是一家临床阶段的生物技术公司，通过开发针对癌症和其他不治之症患者的免疫疗法，重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223928a21a555e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223928a21a555e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACLX","SANA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501352261","title":"Arcellx, Inc.盘中异动 下午盘快速下挫5.07%报75.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501352261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501352261?lang=zh_cn&edition=full","pubTime":"2025-01-07 03:36","pubTimestamp":1736192206,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日03时36分，Arcellx, Inc.股票出现异动，股价急速下挫5.07%。截至发稿，该股报75.12美元/股，成交量62.5482万股，换手率1.16%，振幅6.28%。Arcellx, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Arcellx, Inc.公司简介：Arcellx Inc 是一家临床阶段的生物技术公司，通过开发针对癌症和其他不治之症患者的免疫疗法，重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010703364695faa7ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010703364695faa7ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491351920","title":"Arcellx, Inc.盘中异动 股价大跌5.02%报82.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491351920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491351920?lang=zh_cn&edition=full","pubTime":"2024-12-13 04:38","pubTimestamp":1734035908,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日04时38分，Arcellx, Inc.股票出现异动，股价大幅下挫5.02%。截至发稿，该股报82.61美元/股，成交量31.6348万股，换手率0.59%，振幅6.20%。Arcellx, Inc.股票所在的生物技术行业中，整体跌幅为1.63%。Arcellx, Inc.公司简介：Arcellx Inc 是一家临床阶段的生物技术公司，通过开发针对癌症和其他不治之症患者的免疫疗法，重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121304382895e94335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121304382895e94335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490866472","title":"Arcellx, Inc.盘中异动 早盘大幅上涨5.12%报86.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490866472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490866472?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:15","pubTimestamp":1733930158,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时15分，Arcellx, Inc.股票出现波动，股价急速上涨5.12%。截至发稿，该股报86.48美元/股，成交量3.6732万股，换手率0.07%，振幅3.45%。Arcellx, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Arcellx, Inc.公司简介：Arcellx Inc 是一家临床阶段的生物技术公司，通过开发针对癌症和其他不治之症患者的免疫疗法，重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211231558ab6fe17c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211231558ab6fe17c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX","BK4139","BK4539","CADL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcellx.com","stockEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.0025},{"period":"3month","weight":0.7849},{"period":"6month","weight":0.3225},{"period":"1year","weight":1.1416},{"period":"ytd","weight":0.7606}],"compareEarnings":[{"period":"1week","weight":0.0317},{"period":"1month","weight":-0.0033},{"period":"3month","weight":-0.0196},{"period":"6month","weight":0.0352},{"period":"1year","weight":0.3616},{"period":"ytd","weight":-0.0087}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arcellx, Inc.于2014年12月在特拉华州注册成立。他们是一家临床阶段的生物技术公司，通过为癌症和其他无法治愈的疾病患者开发创新的免疫疗法来重新构想细胞疗法。他们的新型合成结合支架D-Domain旨在克服传统嵌合抗原受体T细胞的局限性。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.032188},{"month":2,"riseRate":0.5,"avgChangeRate":0.129984},{"month":3,"riseRate":0.8,"avgChangeRate":-0.017957},{"month":4,"riseRate":0.2,"avgChangeRate":-0.025222},{"month":5,"riseRate":0.75,"avgChangeRate":0.034373},{"month":6,"riseRate":0.75,"avgChangeRate":0.082898},{"month":7,"riseRate":1,"avgChangeRate":0.108456},{"month":8,"riseRate":0.5,"avgChangeRate":-0.000654},{"month":9,"riseRate":1,"avgChangeRate":0.110918},{"month":10,"riseRate":0.75,"avgChangeRate":0.085436},{"month":11,"riseRate":0.5,"avgChangeRate":0.047548},{"month":12,"riseRate":0.5,"avgChangeRate":0.094424}],"exchange":"NASDAQ","name":"ARCELLX, INC.","nameEN":"ARCELLX, INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ARCELLX, INC.(ACLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ARCELLX, INC.(ACLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ARCELLX, INC.,ACLX,ARCELLX, INC.股票,ARCELLX, INC.股票老虎,ARCELLX, INC.股票老虎国际,ARCELLX, INC.行情,ARCELLX, INC.股票行情,ARCELLX, INC.股价,ARCELLX, INC.股市,ARCELLX, INC.股票价格,ARCELLX, INC.股票交易,ARCELLX, INC.股票购买,ARCELLX, INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ARCELLX, INC.(ACLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ARCELLX, INC.(ACLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}